Objective—Modifications of lipid constituents within atherosclerotic lesions generate
neoepitopes that activate innate and adaptive immune responses. We aimed to define the …

The relationship between autoantibodies to oxidized low density lipoprotein (OxLDL) and
coronary artery disease (CAD) remains controversial. IgM and IgG OxLDL autoantibodies to …

Background—Lipoprotein oxidation plays an important part in atherogenesis.
Autoantibodies to oxidation-specific epitopes of LDL occur in plasma and atherosclerotic …

Atherosclerosis is an inflammatory disease, and the involvement of immune mechanisms in
disease progression is increasingly recognized. Immunization with oxidized low density …

Immunologic research into pathogenic mechanisms operating in autoimmune-mediated
atherosclerosis initially focused on adaptive immunity. Current interest is directed to more …

Autoantibodies against oxidized low-density lipoprotein (LDL) have been reported to be
associated with atherosclerosis. However, data are not consistent. We compared the titres of …

Levels of IgG and IgM autoantibodies (AA) to malondialdehyde (MDA)-LDL and apoB-
immune complexes (ICs) were measured in 748 cases and 1,723 controls in the EPIC …

Objectives Immune responses against oxidized low density lipoprotein (LDL) play a key role
in atherosclerosis. Previous studies have indicated inverse associations between …

Chronic inflammation is believed to be a major, if not the major, pathogenic factor in human
atherosclerosis1, 2). Both innate and adaptive responses have been proposed to play a role …

Autoantibodies to oxidation-specific epitopes of low density lipoprotein (LDL), such as
malondialdehyde-modified LDL (MDA-LDL), occur in plasma and atherosclerotic lesions of …